Hormonal therapy during menopause time may increase risk of breast cancer

Starting hormone therapy at around the time of menopause is associated with a greater risk of breast cancer compared to starting after a longer gap, according to a study published online Jan. 28 in The Journal of the National Cancer Institute.

Direct Link Between Drop In Breast Cancer Rates And Reduced Hormone Therapy

In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer…

New Study: Estrogen Replacement Therapy Speeds Ovarian Cancer Growth

Estrogen therapy used by menopausal women causes a type of ovarian cancer to grow five times faster, according to a new study by researchers at the University of Colorado Cancer Center. Menopausal estrogen replacement therapy (ERT) also significantly increases the likelihood of the cancer metastasizing to the lymph nodes, according to the study, which will be published in the Nov…

Hormone Therapy Linked To Breast Cancer

Using hormone therapy for more than 15 years after menopause increases women’s risk of breast cancer, particularly leaner women, U.S. researchers say.

New Findings Further Clarify Breast Cancer Risk With Hormone Therapy

A new analysis of the California Teachers Study, which analyzed hormone replacement therapy use among 2,857 women for almost 10 years, underscores the need for personalized risk-benefit discussions before women begin hormone therapy. “This is evidence that the story is complicated,” said Tanmai Saxena, an M.D./Ph.D…

« Previous Page — Next Page »